PAID ADVERTISEMENT. This article is a paid advertisement for BOXABL Inc. (Nasdaq: BXBL), distributed by NetworkNewsWire (“NNW”), a division of InvestorBrandNetwork (“IBN”). IBN has been compensated for advertising and digital media services related to BOXABL Inc. Readers should review the full disclaimer at the foot of this article before making any investment decision. BOXABL, transforming … Continue reading “BOXABL Inc. (NASDAQ: BXBL) Strengthens Finance Leadership as Factory-Built Housing Platform Expands Across U.S.”
Volkswagen is exploring a different way to improve electric vehicle range. Rather than simply installing a bigger battery, the German automaker has developed a prototype that focuses on using less energy from the get-go. Called Mission Efficiency, the low and streamlined electric car is designed to show how much energy can be saved through better … Continue reading “VW Prototype Takes EV Efficiency a Notch Higher”
VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, is entering a new phase of development following its transition to the NASDAQ market and a series of scientific and corporate milestones that have expanded the company’s focus around its proprietary BiTAC(R) platform. The Swiss biotechnology company began trading on the NASDAQ Capital … Continue reading “VERAXA Biotech AG (NASDAQ: VRXA) Builds Oncology Pipeline Around BiTAC Platform, Public-Market Story Enters Next Phase”
VERAXA has appointed Raju Willener as Chief Financial Officer, effective immediately. Willener brings more than 30 years of international experience spanning investment banking, corporate finance, asset management and capital markets. His appointment comes as VERAXA advances its proprietary BiTAC platform and a pipeline centered on antibody-drug conjugates and T-cell engagers. VERAXA has reported encouraging early … Continue reading “VERAXA Biotech AG (NASDAQ: VRXA) Adds Capital Markets Veteran as CFO While Advancing BiTAC Oncology Pipeline”
President Donald Trump is facing growing opposition from American voters over the rapid spread of artificial intelligence data centers. A recent NBC News Decision Desk Poll established that 69 percent of survey participants oppose building AI data centers within their local areas, including 45% who strongly oppose the idea. The findings reveal a growing divide … Continue reading “Trump on Collision Course with Voters as Most Americans Oppose Data Centers”
VERAXA Biotech (NASDAQ: VRXA) a developer of next-generation antibody-based cancer therapies, announced the appointment of Raju Willener as chief financial officer, effective immediately. Willener brings more than three decades of international financial leadership experience spanning global capital markets, investment banking, corporate finance, asset management and strategic leadership. He will report to CEO and Co-Founder Christoph … Continue reading “BillionDollarBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Appoints Raju Willener as Chief Financial Officer”
This article has been disseminated on behalf of McEwen Inc. and may include paid advertising. McEwen (NYSE: MUX) (TSX: MUX) announced that its 46.3%-owned subsidiary McEwen Copper Inc. has closed a $240 million senior secured four-year term loan facility to advance engineering and early works at the Los Azules copper project in San Juan, Argentina and for general … Continue reading “BillionDollarBreaks – McEwen Inc. (NYSE: MUX) (TSX: MUX) Announces $240 Million Financing to Advance Los Azules Copper Project”
Chinese electric vehicle (EV) companies are accelerating their expansion into international markets as demand for their vehicles slows at home. After years of strong growth in China, automakers are increasingly looking abroad for new customers and opportunities. China exported around 540,000 electric vehicles in July 2026, marking a record for a single month. At the … Continue reading “Dwindling Domestic Sales Push Chinese EV Makers to Double Down Internationally”
VERAXA Biotech is changing how antibody-based therapies recognize and attack cancer cells, developing antibody-based cancer therapies with an emphasis on bispecific antibody-drug conjugates (“ADCs”) and T-cell engagers (“TCEs”). Its proprietary BiTAC platform uses a dual-targeting, “AND-gated” architecture designed to activate therapeutic effects preferentially at tumor sites. The company has advanced its lead BiTAC-TCE toward IND/CTA-enabling … Continue reading “VERAXA Biotech AG (NASDAQ: VRXA) Builds Antibody-Based Cancer Pipeline Around Dual-Targeting Precision”
More than 600 young people from different parts of the world came together in New York for a United Nations summit focused on artificial intelligence policy and governance. The meeting gave young people an opportunity to discuss how AI should be developed, regulated and used, while also considering its potential to support the UN Sustainable … Continue reading “Hundreds of Young People Join UN Talks on the Future of AI”
